Daunorubicin and Cytarabine (Liposomal) and Sandostatin LAR Depot
Determining the interaction of Daunorubicin and Cytarabine (Liposomal) and Sandostatin LAR Depot and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: cytarabine liposomal / daunorubicin liposomal
Brand name: Vyxeos
Synonyms: Cytarabine and daunorubicin (liposomal)
Generic Name: octreotide
Brand name: Sandostatin, Sandostatin LAR Depot
Synonyms: Sandostatin LAR Depot (injection)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daunorubicin and Cytarabine (Liposomal)-Sandostatin LAR Depot injection
- Daunorubicin and Cytarabine (Liposomal)-Sani-Supp
- Daunorubicin and Cytarabine (Liposomal)-Sani-Supp rectal
- Daunorubicin and Cytarabine (Liposomal)-Sansert
- Daunorubicin and Cytarabine (Liposomal)-Santyl
- Daunorubicin and Cytarabine (Liposomal)-Saphris
- Sandostatin LAR Depot-Daunorubicin and cytarabine liposome Intravenous
- Sandostatin LAR Depot-Daunorubicin citrate
- Sandostatin LAR Depot-Daunorubicin citrate liposome Intravenous
- Sandostatin LAR Depot-Daunorubicin hydrochloride
- Sandostatin LAR Depot-Daunorubicin Intravenous
- Sandostatin LAR Depot-DaunoXome